Gilead Sciences
↗Foster City, California, United States
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company has a dominant legacy in virology, having transformed the treatment landscape for HIV/AIDS and Hepatitis C with market-leading products like Biktarvy and Sovaldi.
In recent years, Gilead has aggressively expanded its portfolio into oncology and inflammation through significant acquisitions, including Kite Pharma (cell therapy) and Immunomedics (antibody-drug conjugates). The company operates globally across more than 35 countries, focusing on long-acting therapies and next-generation curative treatments.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Biotechnology / Virology & Oncology
SIZE & FINANCIALS
Employees:10000+
Revenue:$28B-$29B
Founded:1987
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:Vanguard Group, BlackRock, State Street Global Advisors
STOCK
Exchange:NASDAQ
Ticker:GILD
Market Cap:$117.3B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Biktarvy)
Modalities:Small molecule, mAb, ADC (Antibody-Drug Conjugates), Cell therapy (CAR-T), RNAi
Active Trials:302
Trial Phases:Phase 1: 24 | Phase 2: 15 | Phase 3: 16 | Phase 4: 7
FDA Approvals:25
EMA Approvals:22
CORPORATE STRUCTURE
Subsidiaries:Kite Pharma, CymaBay Therapeutics, Immunomedics, Fosun Kite Biotechnology (Joint Venture)
Key Partnerships:Arcus Biosciences (Oncology), Galapagos NV (Inflammation), Assembly Biosciences (Herpes/Virology), Genesis Therapeutics (AI Discovery)
COMPETITION
Position:Leader
Competitors:GSK (ViiV Healthcare), Merck & Co., AbbVie, Bristol Myers Squibb, Pfizer
LEADERSHIP
Key Executives:
Daniel O'Day - Chairman and CEO
Andrew Dickinson - CFO
Keeley Wettan - EVP, General Counsel
Scientific Founders:Michael L. Riordan
Board Members:Daniel O'Day, Jacqueline Barton, Jeffrey Bluestone, Kelly Kramer
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Gilead Sciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.